Journal profile · ENDOCRINOLOGY & METABOLISM-PERIPHERAL VASCULAR DISEASE
Diabetes & Vascular Disease Research
ISSN 1479-1641 · eISSN 1752-8984 · SAGE Publications Ltd · ENGLAND · Bimonthly · Founded 2004
Diabetes & Vascular Disease Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3; fully open access; APC about USD 2,100; review over 12 weeks (community reports); community-reported acceptance: fairly easy; 25 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetes & Vascular Disease Research is published by SAGE Publications Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Cardiovascular Function and Risk Factors, together about 32.1% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title. It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering. View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM-PERIPHERAL VASCULAR DISEASE
Editor-in-chief Ramzi AjjanPublisher website
Editorial board by country: none in mainland China; most named United States 10, United Kingdom 10, Germany 3, France 2, Italy 2 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine12.5%
- Diabetes Treatment and ManagementMedicine11.5%
- Cardiovascular Function and Risk FactorsMedicine8%
- Diabetes Management and ResearchMedicine5.7%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.6%
- Cardiovascular Health and Disease PreventionMedicine5.3%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine4.6%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3LetPub ·
- Impact factor (publisher)
- 3.1Publisher website ·
- 5-year impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- SJR 2026-06
- 0.91LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 49LetPub ·
- h-index
- 77OpenAlex ·
- i10-index
- 668OpenAlex ·
- 2-year mean citedness
- 2.48OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 22LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 1,065 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 35 | 7 |
| 2025 | 25 | 25 | 91 |
| 2024 | 23 | 23 | 108 |
| 2023 | 33 | 33 | 336 |
| 2022 | 37 | 37 | 498 |
| 2021 | 36 | 36 | 758 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 8.4%Publisher website ·
- Submission to first decision
- 7 daysPublisher website ·
- Acceptance to publication
- 26 daysPublisher website ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,100 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,100 | — | — | |
| Publisher website | USD 2,400 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 200 words
- Manuscript length
- ≤ 1,500 words
- Reference style
- Vancouver
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted11, with length limits
- case studiesThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports.Length not stated
- case studyThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the bod…Length not stated
- correspondenceThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the bod…Length not stated
- discussions of topical issuesThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports.Length not stated
- editorialThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the bod…Length not stated
- meeting reportsThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports.Length not stated
- original paperThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the bod…Length not stated
- original papersThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports.Length not stated
- reviewThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the bod…main text ≤ 2,500 words
- reviewsThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports.Length not stated
- short communicationThe journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the bod…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Member of Committee on Publication Ethics Model summary
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Diabetes & Vascular Disease Research is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, …
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized peer review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Section Editor and Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscript…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1479-1641
- Electronic ISSN
- 1752-8984
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Diabetes & Vascular Disease Research
What CAS zone is Diabetes & Vascular Disease Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetes & Vascular Disease Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetes & Vascular Disease Research?
The latest impact factor listed by LetPub is 3; CiteScore 5.8, h-index 77.
How long does peer review take at Diabetes & Vascular Disease Research?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 8.4%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Diabetes & Vascular Disease Research?
According to the journal's author guidelines: Abstract: ≤ 200 words; Manuscript length: ≤ 1,500 words; Reference style: Vancouver; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Diabetes & Vascular Disease Research based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (10), United Kingdom (10) and Germany (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetes & Vascular Disease Research?
According to LetPub and DOAJ records, Diabetes & Vascular Disease Research is indexed in SCIE, Scopus and DOAJ.
Is Diabetes & Vascular Disease Research open access, and what is the APC?
Diabetes & Vascular Disease Research is a fully open-access journal. APC about USD 2,100.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .